정상 체중인들은 왜 주사형 다이어트 약물을 원하는가?: 체중 편견 내재화의 심리적 동인을 중심으로

초록

The off-label use of GLP-1 weight-loss medications (e.g., Wegovy, Mounjaro) among normal-weight adults for aesthetic purposes is a growing public health concern. This study investigates the psychological mechanisms linking Weight Bias Internalization (WBI) to the intention to use these injections. Integrating the Situational Theory of Problem Solving (STOPS) and Protection Motivation Theory (PMT), structural equation modeling (SEM) was applied to a sample of normal-weight adults. Results revealed that WBI sequentially influences medication intention through situational recognition and coping appraisal. Problem recognition created an ambivalent path, simultaneously increasing perceived response efficacy and response costs. Conversely, involvement recognition strengthened medication intention by significantly lowering perceived response costs. Furthermore, appearance orientation moderated the WBI-response cost relationship; higher appearance orientation heightened perceived costs, acting as a protective mechanism against misuse. These findings elucidate how internalized weight bias translates into specific drug adoption, offering crucial insights for mitigating medication misuse.

키워드